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Impact and cost-effectiveness of a lethal house lure against 
malaria transmission in central Côte d’Ivoire: a two-arm, 
cluster-randomised controlled trial
Eleanore D Sternberg*, Jackie Cook*, Ludovic P Ahoua Alou, Serge Brice Assi, Alphonsine A Koffi, Dimi T Doudou, Carine J Aoura, Rosine Z Wolie, 
Welbeck A Oumbouke, Eve Worrall, Immo Kleinschmidt, Raphael N’Guessan, Matthew B Thomas
Summary
Background New vector control tools are required to sustain the fight against malaria. Lethal house lures, which target 
mosquitoes as they attempt to enter houses to blood feed, are one approach. Here we evaluated lethal house lures 
consisting of In2Care (Wageningen, Netherlands) Eave Tubes, which provide point-source insecticide treatments 
against host-seeking mosquitoes, in combination with house screening, which aims to reduce mosquito entry.
Methods We did a two-arm, cluster-randomised controlled trial with 40 village-level clusters in central Côte d’Ivoire 
between Sept 26, 2016, and April 10, 2019. All households received new insecticide-treated nets at universal coverage 
(one bednet per two people). Suitable households within the clusters assigned to the treatment group were offered 
screening plus Eave Tubes, with Eave Tubes treated using a 10% wettable powder formulation of the pyrethroid 
β-cyfluthrin. Because of the nature of the intervention, treatment could not be masked for households and field 
teams, but all analyses were blinded. The primary endpoint was clinical malaria incidence recorded by active case 
detection over 2 years in cohorts of children aged 6 months to 10 years. This trial is registered with ISRCTN, 
ISRCTN18145556.
Findings 3022 houses received screening plus Eave Tubes, with an average coverage of 70% across the intervention 
clusters. 1300 eligible children were recruited for active case detection in the control group and 1260 in the intervention 
group. During the 2-year follow-up period, malaria case incidence was 2·29 per child-year (95% CI 1·97–2·61) in the 
control group and 1·43 per child-year (1·21–1·65) in the intervention group (hazard ratio 0·62, 95% CI 0·51–0·76; 
p<0·0001). Cost-effectiveness simulations suggested that screening plus Eave Tubes has a 74·0% chance of 
representing a cost-effective intervention, compared with existing healthcare activities in Côte d’Ivoire, and is similarly 
cost-effective to other core vector control interventions across sub-Saharan Africa. No serious adverse events associated 
with the intervention were reported during follow-up.
Interpretation Screening plus Eave Tubes can provide protection against malaria in addition to the effects of 
insecticide-treated nets, offering potential for a new, cost-effective strategy to supplement existing vector control tools. 
Additional trials are needed to confirm these initial results and further optimise Eave Tubes and the lethal house lure 
concept to facilitate adoption.
Funding The Bill & Melinda Gates Foundation.
Copyright © 2021 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 
license.
Introduction
Widescale implementation of core vector control—
specifically long-lasting insecticidal nets and indoor 
residual spraying—has contributed to substantial 
reductions in the burden of malaria.1,2 However, these 
reductions have plateaued2 (probably due to numerous 
causes, including insecticide resistance, poor availability 
or misuse of bednets, urbanisation, and limits on donor 
funding), and new control strategies are needed to attain 
the milestones laid out in the WHO Global Technical 
Strategy for malaria control.3–5
One growing area of interest is the potential role of 
housing improvements.6,7 Many traditional house designs 
in Africa have open eaves (the area where the wall joins 
the roof of a house). Studies have shown that closing the 
eaves can reduce indoor vector abundance8,9 and that 
closed eaves, together with modern housing elements, 
such as metal roofs, window screening, and improved 
doors, are associated with reduced malaria burdens.10–13 
There is also a body of work exploring the potential to 
supplement physical barriers by adding insecticides.14–16 
The In2Care (Wageningen, Netherlands) Eave Tube is one 
such approach, consisting of ventilation tubes made from 
pieces of polyvinyl chloride (PVC) pipe embedded in a 
closed eave.17 Each tube holds a removable insert with 
electrostatically charged netting that can hold powder 
formulations of insecticides (figure 1). Mosquitoes are 
drawn into the Eave Tubes, which funnel the heat and 
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odour cues that normally emanate from the eaves of an 
occupied house. Laboratory bioassays have shown that 
Eave Tube inserts can transfer a high dose of insecticide 
powder to mosquitoes and are even lethal to insecticide-
resistant mosquitoes.18 Semi-field studies in Tanzania,19 
Kenya,20 and Côte d’Ivoire21,22 have shown attraction of 
mosquitoes to the tubes and reduced overnight survival.
We combined Eave Tubes with mosquito-proofing of 
houses (ie, screening of windows and closing gaps) to 
create what WHO describes as a lethal house lure23 
for host-seeking mosquitoes. We refer to this new 
intervention as screening plus Eave Tubes (SET). We 
expected the screening component to provide a physical 
barrier to reduce household entry and the Eave Tubes to 
increase mosquito mortality; thus, SET could provide 
community level protection at sufficiently high coverage.24 
We aimed to evaluate the epidemiological and ento-
mological effects of SET, and its cost-effectiveness, in the 
presence of universal coverage of insecticide-treated nets.
Methods
Study design and participants
We did a two-arm, cluster-randomised controlled 
trial with 20 clusters per group in the Gbêkê region in 
central Côte d’Ivoire. This region has year-round malaria 
transmis sion, with a peak during the wet season 
(May–October). The local malaria vector populations are 
highly resistant to almost all classes of insecticides used 
for vector control.25 The Anopheles gambiae species com-
plex is the dominant species, with A funestus and A nili 
also present.26 We have previously published a detailed 
description of the study protocol.27
We defined clusters as villages separated by at 
least 2 km, with 100–600 houses and at least 80% of the 
houses appearing suitable for modification with SET 
(ie, roofs made from metal sheeting and walls made 
from concrete or brick) during our initial visit.
Between July 10 and July 30, 2016, we did a census in all 
clusters to collect details of household members (age 
and sex), number of insecticide-treated nets available 
to households (provided during a national distribution 
campaign in 2014), and structure of houses. From the 
census list, we randomly selected 60 children (aged 
6 months to 10 years) from each cluster for a baseline 
survey between Aug 4 and Aug 26, 2016. The survey 
collected data on malaria infection status, net use, and 
household assets as a proxy for socioeconomic status. All 
the households in the clusters that were assigned to SET 
Research in context
Evidence before this study
We searched PubMed on May 4, 2020, using the search term 
“malaria” in combination with “housing”, “lethal house lure”, 
or “eaves”, with no restriction on language or dates. The relevant 
results from this search were primarily observational studies 
aimed at identifying risk factors associated with malaria. 
There were also systematic reviews and meta-analyses of survey 
data collected in multiple African countries during Demographic 
and Health Surveys and Malaria Indicator Surveys. These studies 
typically found a reduced risk of malaria for people living in 
improved housing (ie, housing with metal roofs, cement floors, 
and closed eaves). However, few studies tested house 
improvement as an intervention for malaria control, and none 
at the village scale. Of 675 search results, there were only 
four randomised controlled trials that evaluated house 
modifications, all of which were at household level, and only 
three included health outcomes (clinical malaria, parasitaemia, 
or anaemia). These trials evaluated insecticide-treated curtains 
(in Kenya in 1990–91) or house screening (in The Gambia in 
2006–07 and in Ethiopia in 2015–16). In all three trials, there 
was a positive effect on entomological and health outcomes in 
houses that received the intervention compared with control 
houses. For example, the trial in The Gambia found that mean 
mosquito density was 59% lower in households with full 
screening than in households without screening and 47% lower 
in households with screened ceilings. The odds of anaemia in 
children was 47% lower in households with full screening and 
49% lower in households with screened ceilings. However, 
the trial reported no difference in parasitaemia.
Added value of this study
This study is the first cluster-randomised controlled trial to 
evaluate screening plus In2Care (Wageningen, Netherlands) 
Eave Tubes, a new intervention classed as a lethal house lure by 
WHO. To the best of our knowledge, it is the only cluster-
randomised controlled trial that has evaluated combining house 
improvements with targeted insecticide treatment, and it is the 
only village-level trial evaluating house interventions. It is also 
one of a small number of any type of trial evaluating house 
modifications for malaria control.
Implications of all the available evidence
Even without gold standard evidence from randomised controlled 
trials, the idea of mosquito-proof housing for malaria control can 
be traced back more than a century. However, the first systematic 
review of housing and malaria was published just 5 years ago, 
and a Cochrane Review of housing and malaria was completed in 
January, 2021 (protocol published in 2020). This cluster-
randomised controlled trial adds to that evidence base, as the 
first evaluation of screening plus Eave Tubes as a lethal house 
lure approach and Eave Tubes as a novel vector control tool. 
With issues such as insecticide resistance, low coverage and usage, 
and unreliable durability compromising the efficacy of long-
lasting insecticidal nets and indoor residual spraying, new tools 
and interventions like Eave Tubes and screening plus Eave Tubes 
are essential to meet malaria elimination milestones. The results 
of this trial justify screening plus Eave Tubes as a cost-effective 
malaria control intervention that works in an area where malaria 
vectors are highly resistant to insecticide.
Biology, University of York, 
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(intervention clusters) were offered SET if the structure 
of their house was suitable. All households in the 
intervention and control clusters were offered insecticide-
treated nets, regardless of their participation in any other 
aspect of the trial.
We measured epidemiological impact through active 
case detection, with clinical teams systematically screening 
for malaria, in a cohort of 50 randomly selected children 
(aged 6 months to 10 years for the duration of the follow-
up) per cluster. We measured entomological effects using 
human landing catches every month for 2 years in 
randomly selected households.
The trial was reviewed and approved by the 
Côte d’Ivoire Ministry of Health ethics committee 
(039/MSLS/CNER-dkn), the Pennsylvania State Univer-
sity’s Human Research Protection Program under the 
Office for Research Protections (STUDY00003899 and 
STUDY00004815), and the London School of Hygiene & 
Tropical Medicine ethical review board (11223). We obtained 
written and verbal informed consent from all trial 
participants or guardians for participants younger than 
18 years. A trial steering committee monitored trial 
progress and adherence to protocol.
Randomisation and masking
We used restricted randomisation to ensure balanced 
cluster allocation with respect to cluster size, proportion 
of households suitable for the intervention, and presence 
of a health facility within a cluster, as well as to household 
socioeconomic status, malaria infection prevalence in 
cohort aged children, and insecticide-treated net use. 
We generated 10 000 potential sequences for the ran-
domisation using Stata (version 15), one of which was 
picked by random drawing during a public ceremony 
on Sept 7, 2016.
Given the visible nature of SET, it was impossible to 
conceal the cluster allocation from the participants or the 
field workers. However, cluster allocation was masked 
for the processing of samples and all data analyses were 
blinded.
Procedures
In the houses that received SET, work teams installed 
locally sourced PVC tubes (20 cm long with a diameter 
of 15 cm) around 20 cm below the roof at 1·5–2·0 m 
intervals across the outside walls of occupied rooms, such 
as bedrooms and living rooms, but not storage rooms. The 
teams used brick, cement, and plaster to seal open eaves 
and other obvious gaps in the walls and screened the win-
dows using custom-built wooden frames with untreated 
UV-resistant PVC-plasticised glass-fibre enforced netting, 
consisting of 18 × 14 density yarns of 130 g/m² (Copaco 
Screenweavers; Harelbeke, Belgium).
During the installations, work teams placed untreated 
Eave Tube inserts (In2Care; Wageningen, Netherlands) 
into the PVC tubes. After the installations were 
completed in all SET clusters, work teams replaced the 
untreated inserts with inserts treated using a 
10% wettable powder formulation of β-cyfluthrin 
(Tempo Ultra WP; Bayer; Cary, NC, USA). β-cyfluthrin is 
a pyrethroid with existing regulatory approval in Côte 
d’Ivoire and was selected for this trial on the basis of 
initial assays that showed 100% mortality against local 
wild-type mosquitoes using Eave Tubes.22
SET was monitored by teams walking through villages 
every 4 months, and repairs were made as required. 
Every month, the teams collected a random sample of 
four inserts in each SET cluster to monitor persistence of 
the insecticide. Mosquito mortality was assessed using 
Eave Tube bioassays22 with field-collected mosquitoes. 
When inserts from any village produced mortality of 
80% or less, teams began replacing inserts in all the SET 
clusters with freshly treated inserts to ensure that the 
replacement process could be completed before reaching 
the 70% mortality threshold specified in the protocol.
We completed an insecticide-treated net distribution 
cam paign (polyester nets treated with 1·8 g/kg 
deltamethrin; PermaNet 2.0; Vestergaard; Lausanne, 
Switzerland) in all study clusters between March 8 and 
March 19, 2017, according to Côte d’Ivoire’s National 
Malaria Control Program guidelines.
Once the installation of SET and distribution of 
insecticide-treated nets were completed we began epide-
miological and entomological monitoring (figure 2). The 
active case detection cohort children were monitored 
for 2 years unless parents withdrew consent, or the child 
moved out of the cluster. Children lost to follow-up were 
replaced with another child of similar age from the 
same cluster, preferably from the same household or a 
neighbouring household, using the same enrolment 
procedure. Study nurses visited children in the active 
case detection cohort, under the supervision of a medical 
doctor and with the assistance of community health 
workers. At the initial enrolment visit, all children 
received a 3-day course of a first-line antimalarial 
(artesunate-amodiaquine or artemether-lumefantrine), 
to clear any existing malaria parasite infection. A second 
round of parasite clearance took place 1 year later.
At each active case detection visit—once per month 
during the dry season (November–April) and twice per 
Figure 1: A house in Côte d’Ivoire with screening plus Eave Tubes
The inset shows the Eave Tube insert placed within the tube.
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month during the rainy season (May–October)—the 
clinical team recorded the axillary temperature of each 
child. If the child was febrile (axillary temperature 
≥37·5oC) or had a history of fever in the past 48 h or the 
parents reported that their child was sick, the child 
received a physical examination and a record was made 
of symptoms, pulse, and respiratory rate. A finger prick 
blood sample was taken from all febrile children for a 
malaria rapid diagnostic test (SD Bioline Malaria Ag 
P.f/Pan; Standard Diagnostics; Seoul, South Korea). If 
the rapid diag nostic test was positive, the child was 
treated with an antimalarial according to national 
guidelines.
At the start and end of the rainy season (April and 
November) in both study years, all children in the 
cohort received a general physical exam to check for 
any other symptoms, particularly respiratory symptoms. 
We also measured haemoglobin concentrations in 
children aged 5 years and younger using a spectro-
photometer (HemoCue Hb 201+; Radiometer Medical; 
Ängelholm, Sweden) to measure the prevalence of 
anaemia.
For the human landing catch sampling, volunteers 
were recruited from the study clusters to capture 
mosquitoes. Volunteers sat with their legs uncovered 
from 18:00 to 08:00, trapping any mosquitoes that landed 
on their legs in glass haemolysis tubes plugged with 
cotton. Capturers worked in two shifts, from 18:00 to 01:00 
and from 01:00 to 08:00, and were supervised by research 
technicians to ensure they were working according to 
protocol. Catches were done indoors and outdoors for 
one night per month in four randomly selected houses 
per cluster.
Technicians brought the mosquitoes back to the 
laboratory for morphological species identification. A 
random subset of malaria vectors was dissected to assess 
parity. We used PCR to assess sporozoite prevalence in a 
random sample of up to 60 parous females per cluster 
per sampling night (non-parous females were classed as 
uninfected since they had not yet taken a bloodmeal).
We extracted economics data from project expenditure 
records and ethnographic studies of six villages in the 
trial. Costs were recorded in the currency of expenditure 
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Figure 2: Timeline of study activities
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converted to euros and then to US dollars using mean 
exchange rates for the period Sept 1, 2016, to April 02, 2019 
(appendix p 5). Capital items (replacement value for 
one unit >€500 euros and a useful life >1 year) were 
annualised over useful life in the financial analysis and at 
a discount rate of 3% in the economic analysis. The value 
of donated resources (insecticide and community labour) 
was imputed from market rates. We attributed costs 
to initial screening and housing modification, Eave 
Tube installation, insecticide treatment and retreatment 
rounds (comprising insert treatment, insert cleaning, 
and insert insertion and replacement), and housing 
maintenance rounds.
At the end of the trial, we did a cost-effectiveness analysis 
to measure the incremental economic and financial cost 
per malaria case averted and the cost per disability-
adjusted life year (DALY) averted with SET plus insecticide-
treated nets compared with insecticide-treated nets alone, 
under trial conditions from the societal (provider and 
community) and provider perspectives. Trial costs and the 
between-group difference in malaria case incidence were 
combined with malaria case fatality rate estimates and 
population data from the trial and other sources to 
simulate cost-effectiveness endpoints, with DALY averted 
calculated according to standard methods.28 We used 
Monte Carlo simulation in @Risk Software version 7.5 
to explore uncertainty. Further details on the economic 
methods are provided in the appendix (pp 4–7).
Outcomes
The primary outcome of the trial was the incidence of 
clinical malaria (axillary temperature ≥37·5°C and positive 
rapid diagnostic test) in children enrolled in the active case 
detection cohort. The secondary clinical outcome was the 
prevalence of anaemia in children aged 5 years and 
younger (moderate anaemia was defined as 7·0–9·9 g/dL 
haemoglobin and severe anaemia as <7·0 g/dL haemo-
globin). Adverse events were also recorded, including skin 
irritations, headaches, fatigue, diarrhoea, nausea, and 
moderate to severe respiratory symptoms. Any deaths in 
the cohort were followed up with a verbal autopsy by a 
medical doctor if the parents consented.
The key entomological outcomes were the number of 
malaria vectors captured per person per night both 
indoors and outdoors by human landing catches and the 
entomological inoculation rate (EIR; number of infective 
bites per person per year). The key economic outcomes 
were the incremental economic and financial cost 
per malaria case averted, and cost per DALY averted 
with SET plus insecticide-treated nets compared with 
insecticide-treated nets alone.
Other planned secondary outcomes (malaria infection 
in children in the cohorts, parity in malaria vectors, and 
user behaviour, perceptions, and acceptability relating to 
SET) and a supplementary cross-sectional survey that 
measured prevalence of malaria in the study area will be 
reported in future publications.
Statistical analysis
The sample size calculations for epidemiological and 
entomological data collection are published.27 Briefly, we 
designed the study to detect a 40% difference in malaria 
case incidence, assuming a control group incidence of 
0·5 malaria cases per child-year and a coefficient of 
variation of 0·5 between clusters. This design required 
20 clusters per group and 50 children per cluster followed 
for 2 years.
For the entomological sampling, we powered the study 
to detect a 50% reduction in mosquito density, consistent 
with semi-field testing of Eave Tubes19,20 and other 
randomised controlled trials evaluating the entomological 
effect of house modifica tions.12,29 On the basis of baseline 
data, this sample size calculation required seven houses 
per cluster for the human landing catch captures. 
To capture seasonal variation, we repeated sampling 
throughout the trial. For logistical reasons, we did human 
landing catch captures in four randomly selected houses 
every month and pooled the data every 2 months.
We used Stata (version 15) to analyse epidemiological 
and entomological data. The primary intention-to-treat 
See Online for appendix
Figure 3: Study profile
40 eligible clusters
20 control clusters (insecticide-treated nets 
only)
20 intervention clusters (screening plus 
Eave Tubes plus insecticide-treated nets)
4168 houses
15 052 insecticide-treated nets distributed
4222 houses
3021 houses received screening plus Eave Tubes
14 692 insecticide-treated nets distributed
7655 eligible children 7447 eligible children
Total
3635 cases
1597·7 child-years time at risk
Total
2355 cases
1655·6 child-years time at risk
121 lost to follow-up
6 deaths
Year 1 (May 1, 2017–April 31, 2018)
1076 children enrolled
1079 malaria cases
 735·3 child-years time at risk
Year 1 (May 1, 2017–April 31, 2018)
1088 children enrolled
778 malaria cases
762·3 child-years total time at risk
Year 2 (May 1, 2018–April 31, 2019)
224 new children enrolled
2556 malaria cases
862·4 child-years total time at risk
Year 2 (May 1, 2018–April 31, 2019)
172 new children enrolled
1577 malaria cases
893·4 child-years time at risk
117 lost to follow-up
1 death
137 lost to follow-up
3 deaths
102 lost to follow-up
2 deaths
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analysis was a comparison of the incidence of clinical 
malaria episodes between the two groups. We considered 
that a child would not be at risk for 2 weeks following 
any treatment. Malaria cases detected within 4 weeks 
of a previous malaria case were not counted as a new 
case, to allow for circulating histidine-rich protein after 
parasite clearance.30 Per protocol analyses involved 
comparison of children who lived in houses with SET 
installed with those in the control clusters. Sensitivity 
analysis included increasing the censoring period 
fol lowing treatment to 4 weeks or requiring at least 
one negative visit following a positive diagnosis before 
follow-up time was uncensored. Children were allowed 
to drop out and re-enter the cohort if they were away 
from their home village for an extended period of time 
(eg, for school holidays); if a child was not visited for a 
period of more than 6 weeks, we did not include this 
period in the follow-up time. We attempted to replace 
children lost from the cohort with children of a similar 
age from the same household, if possible, or from a 
randomly selected neighbouring household. We also 
assessed the effect of year and possible confounders 
such as age, socioeconomic status, and cluster baseline 
infection prevalence.
We used survival analysis to compare the risk of having 
a malaria case in each group using a Cox proportional 
hazards model allowing for multiple events per child 
and using robust estimates of variance to account for 
the clustered design. The effect of the intervention on 
anaemia was estimated using mixed effects logistic 
models with child included as a random effect to account 
for repeated measures and robust standard errors.
We calculated a proxy for socioeconomic status for each 
child, incorporating information about household wall 
type, toilet type, access to electricity, access to water, and 
household assets (bicycle, motorbike, television, radio, 
refrigerator, and livestock) into a principal components 
analysis. The subsequent socioeconomic status score was 
divided into tertiles. To assess the effect of SET coverage, 
we compared villages with SET coverage of more than 
70% coverage and of 70% or less, with control villages 
using Cox regression. We used the 70% threshold on the 
basis of modelling outputs showing community-wide 
benefits at this threshold24 and to allow a balanced 
number of clusters on either side of the threshold. We 
used the same Cox regression model described above 
to model the relationship between SET coverage and 
incidence in the intervention clusters, whilst controlling 
for baseline cluster prevalence.
Indoor and outdoor mosquito density (malaria vectors 
only) was calculated for each household visit. A pooled 
EIR was calculated for each cluster at each visit (12 visits 
total). All non-parous mosquitoes were assumed to be 
sporozoite negative. EIR was calculated as follows:
To analyse mosquito density and EIR, we used mixed 
effects generalised linear mixed models with a negative 
binomial distribution, controlling for collection time-
point as a categorical fixed effect. Cluster was included in 
the model as a random effect.
This study is registered as an International Standard 
Randomised Controlled Trial, ISRCTN18145556.
Role of the funding source
The funder of the study had no role in study design, data 
collection, data analysis, data interpretation, or writing of 
the report. EDS and JC had full access to all the data in the 
study, and EDS had final responsibility for the decision to 
 Annual EIR=




Total tested + Total nonparous
× ×
Control group Intervention group
Cluster characteristics (July, 2016)
Number of clusters 20 20
Mean number of houses per cluster (range) 201 (106–354) 205 (102–353)
Mean population per cluster (range) 1365 (598–2382) 1351 (655–2332)
Percentage of households with adequate 
numbers of long-lasting insecticidal nets 
(95% CI)*
39·5% (34·1–44·8) 43·6% (36·6–50·6)
Baseline cross-sectional (August, 2016)
Mean number of children aged 6 months to 
10 years surveyed per cluster (range)
63 (52–94) 64 (50–95)
Mean age, years (range) 4·6 (0·5–9·6) 4·7 (0–8·8)
Percentage of children living in houses of 
suitable structure for screening plus Eave Tubes 
(95% CI)
87·9% (80·7–95·1) 92·3% (88·2–96·4)
Malaria infection prevalence (95% CI) 73·9% (68·1–79·7) 72·4% (66·4–78·3)
Entomological characteristics—human landing catches (December, 2016)
Mean number of vectors found indoors per house 
per night (95% CI), n
29·8 (14·3–45·3), 3575 25·8 (6·4–45·2), 2836
Mean number of vectors found outdoors per 
house per night (95% CI), n
26·4 (13·7–39·2), 3173 21·6 (4·4–38·9), 2381
Characteristics of children at enrolment (April–May, 2017)
Age, percentage (95% CI)
≤2 years 9·4% (7·4–11·8) 9·7% (7·6–12·3)
>2–5 years 38·4% (34·6–42·3) 35·6% (32·3–39·1)
>5–8 years 52·3% (48·0–56·5) 54·7% (51·2–58·2)
Sex, percentage (95% CI)
Male 50·5% (47·5–53·5) 50·1% (47·8–52·3)
Female 49·5% (46·5–52·6) 49·7% (47.7–52.2)
Proportion of children reporting using a net the 
night before enrolment (95% CI)
58·0% (43·9–72·1) 55·8% (42·4–69·1)
Proportion of children living in houses with 
screening plus Eave Tubes (95% CI)
·· 82·5% (77·1–87·9)
Malaria case prevalence (95% CI) 3·2% (1·2–5·3) 4·2% (1·7–6·6)
Anaemia prevalence in children ≤5 years† 
(95% CI)
40·6% (28·5–52·7) 36·5% (28·8–44·2)
CIs are calculated at the individual (epidemiological) or household (vector density) level and adjusted for clustering by 
village. *One net for every two people. †Anaemia was clinically diagnosed as <9·9 g/dL.
Table 1: Baseline characteristics
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submit for publication. In2Care (the technology provider) 
was involved in putting together the grant proposal to 
secure funding from the Bill & Melinda Gates Foundation 
for the trial. In2Care also installed and maintained the 
technology (screening plus Eave Tubes) throughout the 
trial. The study design, conduct, analysis, and write up 
was done independently of In2Care, by the authors named 
on the paper.
Results
The study area included 8390 houses with 55 404 inhabi-
tants at the time of the census (figure 3). We installed 
SET from Sept 26, 2016, to Feb 26, 2017, and installed 
treated inserts between April 15 and May 22, 2017, 
before enrolment of children in the village. There 
were 4222 houses in the intervention group, of which 
3021 (72%) received SET, resulting in cluster-level 
coverage ranging from 32% to 100% (median 73%). 
15 052 insecticide-treated nets were distributed in the 
control group and 14 692 in the intervention group, with 
an average of one net for every 1·9 people in the control 
group and every 1·8 people in the intervention group 
(figure 3). The groups did not differ on cluster size, 
previous net ownership, children living in houses 
suitable for SET, or malaria infection prevalence (table 1).
We recruited 1300 children in the control group and 
1260 in the intervention group over the 2-year period 
for active case detection, giving a follow-up time of 
3253 child-years. At enrolment, children were balanced 
on age, sex, and net use. A similar propor tion of children 
were febrile and had detectable malaria parasites at 
enrolment in each group (33 [3·2%] of 1022 in the control 
group vs 43 [4·2%] of 1031 in the intervention group). 
Entomological data collected between Nov 24 and 
Dec 17, 2016 (before installation of treated inserts), 
showed fewer vectors in the intervention group both 
indoors and outdoors (table 1).
During the 2-year follow-up period, bednet use 
the previous night was reported at 24 270 (67·2%) of 
36 095 visits for the control group and at 21 428 (59·0%) of 
36 316 visits for the intervention group. We detected 
5990 malaria cases. Malaria case incidence was 2·29 per 
child-year (95% CI 1·97–2·61) in the control group and 
1·43 per child-year (1·21–1·65) in the intervention group 
(hazard ratio [HR] 0·62, 95% CI 0·51–0·76; p <0·0001; 
table 2). Malaria case incidence was higher in both groups 
in the second study year, with a slightly larger dif-
ference between the groups (0·60, 0·47–0·78; p <0·0001) 
compared with year 1 (0·70, 0·59–0·82; p<0·0001; 
figure 4; table 2). Interactions between covariates (age, 
study year, socioeconomic status, or baseline prevalence) 
and group were not significant.
Overall prevalence of anaemia reduced from 38·5% 
(346 of 898) at baseline to 14·5% (108 of 747) 6 months 
later and remained similar throughout follow-up. The 
odds of anaemia in children living in intervention 
clusters was 30% lower than those living in control 
clusters (odds ratio 0·69, 95% CI 0·49–0·99; p=0·046; 
table 3). Only ten instances of severe anaemia were 
recorded during the study period.
The range in SET coverage enabled an exploration 
of the potential dose-response effect of intervention 
coverage. However, such an analysis was not included in 
the analysis plan, and the trial was not powered for this 
purpose, so insights into coverage should be treated with 
Control group Intervention group Hazard ratio p value














Overall 3635 1597·7 2·29 (1·97–2·61) 2355 1655·6 1·43 (1·21–1·65) 0·62 (0·51–0·76) <0·0001
Year 1 1079 735·3 1·47 (1·28–1·67) 778 762·3 1·02 (0·92–1·12) 0·70 (0·59–0·82) <0·0001
Year 2 2556 862·4 3·00 (2·52–3·48) 1577 893·4 1·79 (1·41–2·17) 0·60 (0·47–0·78) <0·0001
Hazard ratios derived from Cox regression, with robust standard errors for cluster, are presented.
Table 2: Malaria case incidence in children aged 6 months to 10 years
Figure 4: Cluster-level malaria case incidence by month for the 2-year follow-up
Open circles show cluster-level malaria case incidence, and closed diamonds show the mean of the cluster 
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caution. In clusters where coverage was greater than 
70% (13 clusters), risk of a malaria case was 47% lower 
compared with control clusters (HR 0·53, 95% CI 
0·43–0·65; p<0·0001). In clusters with 70% coverage or 
less (seven clusters), there was some benefit compared 
with control villages (0·79, 0·63–1·00; p=0·050). There 
was a strong association between incidence and SET 
coverage, with a 10% decrease in incidence for every 
10% increase in SET coverage, controlling for baseline 
prevalence (0·90, 0·52–0·94; p<0·0001; figure 5).
Per-protocol analysis (ie, only including children living 
in households that received nets in the control group 
and nets and SET in the intervention group) showed a 
slightly higher effect than the intention-to-treat analysis 
(HR 0·59, 95% CI 0·48–0·72; p<0·0001). 214 (17%) of 
2160 children in the intervention group were living in 
houses without SET, which enabled us to examine 
whether those children benefitted from a community 
effect. Because children that did not live in houses with 
SET were more likely to live in houses not suitable for 
the intervention (often associated with lower socio-
economic status), we included socioeconomic status 
tertile as a fixed effect in the model. There was evidence 
that children living in intervention clusters, but without 
the intervention, were at lower risk of having a case of 
malaria than those living in control clusters (HR 0·73, 
95% CI 0·54–0·99; p=0·042). This effect was not present 
in clusters where SET coverage was 70% or less (0·96, 
0·78–1·19; p=0·73).
Respiratory infections were rare, with no difference 
between the two groups (HR 1·00, 95% CI 0·71–1·41; 
p=0·99). Other adverse events recorded are noted in the 
appendix (p 2). No serious adverse events associated 
with the intervention were reported during the trial. 
During the 2-year follow-up, 12 children died (nine in 
the control group, and three in the intervention group). 
Five of the deaths were caused by malaria (three in the 
control group, and two in the intervention group).
Mean indoor mosquito density was substantially 
reduced in the intervention group (24·7 [95% CI 
15·1–34·3] in the control group vs 13·0 [5·9–20·1] in the 
intervention group) with mosquito density ratio of 0·39 
(95% CI 0·20–0·74; p=0·0040). There was also some 
evidence of a reduction in mean outdoor mosquito 
density (mosquito density ratio 0·61, 95% CI 0·34–1·10; 
p=0·099; table 4).
EIR was substantially reduced in the intervention group 
both indoors and outdoors. Indoor annual EIR was 
170 infectious bites per person (95% CI 131–210) in the 
Control group Intervention group Odds ratio p value
Number of 
anaemia tests




Prevalence of anaemia 
(95% CI)
Overall 1171 16·2% (13·9–18·6) 1162 12·1% (9·2–15·0) 0·69 (0·49–0·99) 0·046
Year 1 621 17·4% (13·8–21·0) 643 13·4% (9·4–17·4) 0·70 (0·43–1·15) 0·16
Year 2 550 14·9% (12·0–17·9) 519 10·6% (7·3–13·8) 0·59 (0·34–1·02) 0·061
Haemoglobin tests for anaemia were done at the start and end of each transmission season in children aged 5 and younger. The first study year includes anaemia tests done 
7 months after intervention. The second year includes tests done at 12 months, 19 months, and 24 months after intervention. Odds ratios derived from mixed effect logistic 
regression, with a random effect for child and robust standard errors for cluster, are presented for prevalence of anaemia.
Table 3: Prevalence of anaemia in children aged 6 months to 10 years 
















0·39 (0·20–0·74) ·· 0·0040
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inoculation rate 

















0·61 (0·34–1·10) ·· 0·099
Entomological 
inoculation rate 









*Adjusted for collection visit.
Table 4: Entomological outcomes by intervention and location for malaria vectors
Figure 5: Association between SET coverage and malaria case incidence
Each circle represents a cluster. SET=screening plus Eave Tubes.
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control group and 53 infectious bites per person (34–71) 
in the intervention group (rate ratio [RR] 0·28, 95% CI 
0·16–0·50; p<0·0001). Outdoor EIR was 165 infectious 
bites per person (95% CI 123–206) in the control group 
and 61 infectious bites per person (38–96) in the treatment 
group (RR 0·33, 95% CI 0·19–0·57; p<0·0001).
Total economic costs of the intervention were US$239·46 
per house covered from the societal perspective and 
$215·38 per house from the provider perspective 
(appendix pp 9, 25). The total annualised societal-
perspective economic costs of delivering screening and 
Eaves Tube was $723 421·06, with 96·7% of these costs 
($699 388·64 of $723 421·06) attributed to non-capital 
items and 3·3% ($24 032·42 of $723 421·06) attributed 
to capital items (appendix pp 8, 19). Providers bore 
89·9% of these costs ($650 676·72 of $723 421·06), with 
the remaining 10·1% borne by communities (appendix 
pp 8, 19). Total costs were comprised of 40·0% for 
screening installation ($289 566·13 of $723 421·06), 
39·5% for Eave Tubes installation ($285 537·93 of 
$723 421·06) and 20·5% for the six maintenance and 
retreatment rounds ($148 317·01 of $723 421·06; appendix 
pp 8, 21).
Cost-effectiveness simulations using model inputs 
(appendix pp 17–18) indicated the estimated median 
societal cost per case averted was $28·91 per year 
(90% credible interval 6·82–74·21) and median cost per 
DALY averted was $210·29 per year (46·16–553·57). 
The equivalent provider-perspective cost-effectiveness 
estimates for cost per case averted was $26·44 per year 
(6·25–67·50) and cost per DALY averted was $192·30 per 
year (42·48–506·27; appendix pp 9, 26). Benchmarking 
against nationally relevant decision rules for Côte d’Ivoire 
indicates that SET has a 74·0% chance of representing a 
cost-effective intervention (appendix pp 10–11, 33–34).
Discussion
In this 2-year trial, children living in the clusters with 
SET and insecticide-treated nets were 38% less likely 
to have a malaria case than children living in clusters 
with insecticide-treated nets alone. There was also a 
substantial reduction in the number of infective bites, 
with malaria vector populations and EIRs more than 
halved indoors and outdoors, in SET clusters compared 
with control clusters. Numerous laboratory, semi-field, 
and modelling studies have been suggestive of the 
potential of SET,20,21,24,27 but this is the first trial done at 
sufficient scale to show an epidemiological effect. These 
results are encouraging for SET as a novel malaria 
control intervention.
The lethal house lure approach we tested was a 
combination of targeted delivery of insecticides using 
In2Care Eave Tubes with house improvement (screening 
and general repairs) to reduce mosquito entry. We 
expected SET to have a better chance of reducing 
transmission compared with either screening or Eave 
Tubes alone. We observed a substantial reduction in 
mosquito densities indoors, but the intervention did not 
completely prevent mosquito entry, partly because 
perfect mosquito proofing is difficult to achieve but also 
because householders do not keep doors and windows 
closed at all times. However, because of the insecticidal 
action of the Eave Tubes, mosquitoes could have 
been killed even after they had entered the house 
if they attempted to exit through the Eave Tubes.21 The 
contribution of the insecticidal component is further 
supported by the reduction in mosquito densities that 
we observed outdoors. An overall reduction in density 
could benefit the whole community, making SET more 
equitable, because its effects extend to households that 
might not be suitable for the intervention themselves.
Coverage of SET was generally good (average of 
73% across all clusters), reflecting the good acceptability 
of the intervention to householders (DTD, unpublished 
data). Houses did not receive the intervention if the 
homeowner did not consent, if the occupants did not 
own the property (ie, rental properties), or if the instal-
lation team determined that SET could not be safely 
installed without damaging the house. This variation 
resulted in a range of coverages of SET in our clusters, 
enabling exploratory analyses that suggest a positive 
relationship between SET coverage and reduction in 
malaria. This pattern is further supported by data 
showing that the frequency of clinical malaria was 
reduced in children living in households without SET if 
the cluster had more than 70% coverage with SET. These 
results are consistent with community protection, but 
the trial was not designed to test this hypothesis.
Although the distribution of insecticide-treated nets in 
the trial clusters followed National Malaria Control 
Program guidelines and recipients of SET were requested 
to continue using their insecticide-treated nets, lower 
bednet use was still reported in clusters that received 
SET than in those that did not. Whether this reduced use 
was due to some perceived benefit of the SET intervention 
by householders is unknown, but one feature of SET is 
that it is a passive technology once it is installed, and it 
protects anyone sleeping in the house without requiring 
any specific behaviour. Despite universal coverage of 
insecticide-treated nets in this trial, malaria transmission 
remained substantial, emphasising the need for new 
interventions, such as SET, and further combinations of 
interventions.
We selected a commercially available pyrethroid for 
this trial. Although central Côte d’Ivoire is an area 
of intense pyrethroid resistance, early evaluation of 
candidates found that this product had good efficacy 
when delivered in an Eave Tube due to a high dose 
transfer of insecticide powder from the electrostatic 
netting.18,22 Inserts collected from villages reliably 
produced mortality of more than 80% in bioassays with 
local mosquitoes up to 4 months following treatment, at 
which point all inserts were retreated. Persistence of the 
insecticide under the field trial conditions was shorter 
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than suggested in the initial studies (4 months under 
village conditions compared with >9 months in earlier 
laboratory tests and studies of experimental huts).22 
Although this delivery method was effective against the 
local mosquito population, and pyrethroids are reliable 
and safe for malaria vector control with existing 
regulatory approval across many countries, continued 
use of pyrethroids is not ideal for insecticide resistance 
management. Nonetheless, the trial provides essential 
proof of principle of the novel insecticide delivery system. 
Much like the early days of insecticide-treated nets, there 
is potential for further product development to improve 
performance and explore different active ingredients for 
use in novel resistance management strategies. This 
development would need to include a supply chain and 
business model for the distribution and replacement of 
inserts, as well as extending the longevity of insecticide 
on the inserts, work that is being done by In2Care.
Our cost-effectiveness analysis found that, in terms of 
cost per case averted, SET appears within the range of 
other key, cost-effective, malaria control interventions. 
Although the cost per DALY averted exceeds that for 
other interventions from older studies, it is widely 
accepted that new interventions are needed, and that 
these are unlikely to be as effective at driving down 
transmission as the primary interventions have been. 
Furthermore, if economies of scale can be achieved in 
SET (as they are with indoor residual spraying) then the 
difference between these two interventions will be 
reduced. Additionally, disentangling the relative contri-
butions of the screening and Eave Tubes, to the overall 
impact of SET, could provide opportunities for optimisa-
tion of the intervention to improve cost-effectiveness. 
Because the cost of screening is roughly equivalent to the 
cost of Eave Tubes, if the insecticidal activity alone 
provides protection from malaria (eg, through mosquito 
mortality observed in an experimental hut study of Eave 
Tubes21), then there could be an alternative model for 
deploying Eave Tubes alone.
As with any house improvement intervention, SET is a 
complex intervention to implement at scale. Despite the 
effect of housing on health outcomes, housing is not 
considered the domain of public health, and house 
improvement does not fit into existing public health 
product distribution pathways, such as mass drug admin-
istration, bednet distributions, or even indoor residual 
spraying campaigns. Moreover, modification of people’s 
homes can be considered intrusive. Because these chal-
lenges are com mon to any vector control effort targeting 
the built environment, they are already the focus of 
ongoing discussions.6,31 The emerging consensus is 
that suc cessful implementation of house-based malaria 
control interventions will require us to rethink distribution 
pathways and rely on multisectoral collaborations at every 
level. Rapid economic and population growth in sub-
Saharan Africa means that millions of new houses will be 
built in the coming decade and millions more existing 
houses will be retrofitted with modern housing features.13 
Clear and easy pathways therefore need to be created for 
the implementation of SET and other house improvement 
interventions. Failing to move forward on housing and 
malaria would be a monumental missed opportunity.
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